Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J. 2021;134:783–91.

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Zheng J, Hao J, Wang RR, Liu X, Gu P, et al. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019. Cancer Med. 2022;11:1310–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res. 2021;149:1–61.

Article  CAS  PubMed  Google Scholar 

Farah M, Anugwom C, Ferrer JD, Baca EL, Mattos AZ, Possebon JPP, et al. Changing epidemiology of hepatocellular carcinoma in South America: a report from the South American liver research network. Ann Hepatol. 2023;28:100876.

Article  PubMed  Google Scholar 

Tran NH. Shifting epidemiology of hepatocellular carcinoma in far eastern and southeast Asian patients: explanations and implications. Curr Oncol Rep. 2022;24:187–93.

Article  PubMed  Google Scholar 

Lliovet, J. M. et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.

Konyn P, Ahmed A, Kim D. Current epidemiology in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2021;15:1295–307.

Article  CAS  PubMed  Google Scholar 

Mehta N, Bhangui P, Yao FY, Mazzaferro V, Toso C, Akamatsu N, et al. Liver transplantation for hepatocellular carcinoma. working group report from the ILTS transplant oncology consensus conference. Transplantation. 2020;104:1136–42.

Article  PubMed  Google Scholar 

Berenguer M, Burra P, Ghobrial M, Hibi T, Metselaar H, Sapisochin G, et al. Posttransplant management of recipients undergoing liver transplantation for hepatocellular carcinoma. Working group report from the ILTS transplant oncology consensus conference. Transplantation. 2020;104:1143–9.

Article  PubMed  Google Scholar 

Bednarsch J, Czigany Z, Heise D, Joechle K, Luedde T, Heij L, et al. Prognostic evaluation of HCC patients undergoing surgical resection: an analysis of 8 different staging systems. Langenbecks Arch Surg. 2021;406:75–86.

Article  PubMed  Google Scholar 

Zhang W, Zhang B, Chen XP. Adjuvant treatment strategy after curative resection for hepatocellular carcinoma. Front Med. 2021;15:155–69.

Article  PubMed  Google Scholar 

Tellapuri S, Sutphin PD, Beg MS, Singal AG, Kalva SP. Staging systems of hepatocellular carcinoma: a review. Ind J Gastroenterol. 2018;37:481–91.

Article  Google Scholar 

Tumen D, Heumann P, Gulow K, Demirci CN, Cosma LS, Muller M, et al. Pathogenesis and current treatment strategies of hepatocellular carcinoma. Biomedicines. 2022;10:3202.

Article  PubMed  PubMed Central  Google Scholar 

Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150:835–53.

Article  PubMed  Google Scholar 

Ahn JC, Teng PC, Chen PJ, Posadas E, Tseng HR, Lu SC, et al. Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma. Hepatology. 2021;73:422–36.

Article  PubMed  Google Scholar 

Salazar J, Le A. The heterogeneity of liver cancer metabolism. Adv Exp Med Biol. 2021;1311:127–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laughlin KM, Luo D, Liu C, Shaw G, Warrington KH Jr, Law BK, et al. Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest. Differentiation. 2009;78:35–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Varisli L. Decreased expression of HN1 sensitizes prostate cancer cells to apoptosis induced by docetaxel and 2-methoxyestradiol. Ann Clin Lab Sci. 2022;52:196–201.

CAS  PubMed  Google Scholar 

Zhang C, Xu B, Lu S, Zhao Y, Liu P. HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity. Mol Cancer. 2017;16:90.

Article  PubMed  PubMed Central  Google Scholar 

Pan Z, Fang Q, Li L, Zhang Y, Xu T, Liu Y, et al. HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1. Cancer Lett. 2021;501:31–42.

Article  CAS  PubMed  Google Scholar 

Wang R, Fu Y, Yao M, Cui X, Zhao Y, Lu X, et al. The HN1/HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin. FEBS J. 2022;289:6400–19.

Article  CAS  PubMed  Google Scholar 

Chen J, Qiu J, Li F, Jiang X, Sun X, Zheng L, et al. HN1 promotes tumor associated lymphangiogenesis and lymph node metastasis via NF-kappaB signaling activation in cervical carcinoma. Biochem Biophys Res Commun. 2020;530:87–94.

Article  CAS  PubMed  Google Scholar 

Goto T, Tokunaga F, Hisatomi O. Hematological- and neurological-expressed sequence 1 gene products in progenitor cells during newt retinal development. Stem Cells Int. 2012;2012:436042.

Article  PubMed  PubMed Central  Google Scholar 

Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology. 2004;40:667–76.

Article  CAS  PubMed  Google Scholar 

Lee JS, Thorgeirsson SS. Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets. Gastroenterology. 2004;127:S51–55.

Article  CAS  PubMed  Google Scholar 

Woo HG, Park ES, Cheon JH, Kim JH, Lee JS, Park BJ, et al. Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma. Clin Cancer Res. 2008;14:2056–64.

Article  CAS  PubMed  Google Scholar 

Kim SM, Leem SH, Chu IS, Park YY, Kim SC, Kim SB, et al. Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma. Hepatology. 2012;55:1443–52.

Article  PubMed  Google Scholar 

Nault JC, De Reynies A, Villanueva A, Calderaro J, Rebouissou S, Couchy G, et al. A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection. Gastroenterology. 2013;145:176–87.

Article  CAS  PubMed  Google Scholar 

Ricoult SJ, Yecies JL, Ben-Sahra I, Manning BD. Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP. Oncogene. 2016;35:1250–60.

Article  CAS  PubMed  Google Scholar 

Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI, et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 2011;14:21–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Q, Lin X, Wang G. Targeting SREBP-1-mediated lipogenesis as potential strategies for cancer. Front Oncol. 2022;12:952371.

Article  CAS  PubMed  PubMed Central